Xiaosong Ding
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
Papers in
-
- Acute Myocardial Infarction Research 15
- Blood Pressure and Hypertension Studies 2
- Atrial Fibrillation Management and Outcomes 2
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Hui Chen (24 shared papers)Hongwei Li (19 shared papers)Weiping Li (13 shared papers)Qingbo Liu (7 shared papers)Bing Hua (5 shared papers)Xue-Qiao Zhao (7 shared papers)Hui Gao (3 shared papers)Hehe Cui (3 shared papers)
- Journals
- Journal of Atherosclerosis and Thrombosis (2 papers)Journal of Translational Medicine (2 papers)Molecular and Cellular Endocrinology (1 paper)International Journal of Oncology (1 paper)The American Journal of Cardiology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaosong Ding
29 papers receiving 586 citations
Peers
Comparison fields: 5 of 54
- Endocrinology, Diabetes and Metabolism 222
- Cardiology and Cardiovascular Medicine 139
- Oncology 110
- Cancer Research 53
- Nephrology 20
Countries citing papers authored by Xiaosong Ding
This map shows the geographic impact of Xiaosong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Ding more than expected).
Fields of papers citing papers by Xiaosong Ding
This network shows the impact of papers produced by Xiaosong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Ding. The network helps show where Xiaosong Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaosong Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 77 | |
| 2 | 2019 | 75 | |
| 3 | 2021 | 74 | |
| 4 | 2019 | 53 | |
| 5 | 2021 | 47 | |
| 6 | 2019 | 45 | |
| 7 | 2020 | 41 | |
| 8 | 2014 | 35 | |
| 9 | 2017 | 19 | |
| 10 | 2020 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2012 | 14 | |
| 13 | 2017 | 12 | |
| 14 | 2019 | 12 | |
| 15 | 2020 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2016 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2020 | 5 |
About Xiaosong Ding
Xiaosong Ding is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research, having authored 33 papers that have together received 609 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (15 papers), Coronary Interventions and Diagnostics (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Blood Pressure and Hypertension Studies (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (222 citations), Cardiology and Cardiovascular Medicine (139 citations), Oncology (110 citations), Cancer Research (53 citations) and Nephrology (20 citations). Xiaosong Ding has collaborated with scholars based in China and United States. Frequent co-authors include Hui Chen, Hongwei Li, Weiping Li, Qingbo Liu, Bing Hua, Xue-Qiao Zhao, Hui Gao, Hehe Cui, Xue-Qiao Zhao and Yuehong Li. Their work appears in journals such as Journal of Atherosclerosis and Thrombosis, Journal of Translational Medicine, Molecular and Cellular Endocrinology, International Journal of Oncology and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.